Javitt Daniel C. 4
4 · NRX Pharmaceuticals, Inc. · Filed Nov 18, 2022
Insider Transaction Report
Form 4
Javitt Daniel C.
10% Owner
Transactions
- Sale
common stock
2022-11-16$1.02/sh−133,719$136,393→ 9,689,982 total(indirect: By LLC) - Sale
common stock
2022-11-17$1.05/sh−33,018$34,745→ 9,656,964 total(indirect: By LLC)
Footnotes (2)
- [F1]Sale was pursuant to the terms of a 10b5-1 trading plan established on June 13, 2022.
- [F2]Held by Glytech LLC of which the Reporting Person is the sole owner.